- Home
- ELAB vs EVGN Comparison
ELAB vs EVGN Comparison
Compare ELAB & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELAB
- EVGN
- Stock Information
- Founded
- ELAB 2020
- EVGN 1999
- Country
- ELAB United States
- EVGN Israel
- Employees
- ELAB N/A
- EVGN N/A
- Industry
- ELAB
- EVGN Agricultural Chemicals
- Sector
- ELAB
- EVGN Industrials
- Exchange
- ELAB Nasdaq
- EVGN Nasdaq
- Market Cap
- ELAB 6.6M
- EVGN 7.3M
- IPO Year
- ELAB 2023
- EVGN N/A
- Fundamental
- Price
- ELAB $2.32
- EVGN $1.40
- Analyst Decision
- ELAB
- EVGN Strong Buy
- Analyst Count
- ELAB 0
- EVGN 1
- Target Price
- ELAB N/A
- EVGN $3.50
- AVG Volume (30 Days)
- ELAB 1.5M
- EVGN 5.5M
- Earning Date
- ELAB 08-13-2025
- EVGN 08-21-2025
- Dividend Yield
- ELAB N/A
- EVGN N/A
- EPS Growth
- ELAB N/A
- EVGN N/A
- EPS
- ELAB N/A
- EVGN N/A
- Revenue
- ELAB N/A
- EVGN $6,765,000.00
- Revenue This Year
- ELAB N/A
- EVGN N/A
- Revenue Next Year
- ELAB N/A
- EVGN $113.18
- P/E Ratio
- ELAB N/A
- EVGN N/A
- Revenue Growth
- ELAB N/A
- EVGN N/A
- 52 Week Low
- ELAB $1.95
- EVGN $0.95
- 52 Week High
- ELAB $839.86
- EVGN $7.19
- Technical
- Relative Strength Index (RSI)
- ELAB 45.60
- EVGN 47.35
- Support Level
- ELAB $1.96
- EVGN $1.27
- Resistance Level
- ELAB $2.20
- EVGN $1.34
- Average True Range (ATR)
- ELAB 0.12
- EVGN 0.12
- MACD
- ELAB 0.03
- EVGN -0.03
- Stochastic Oscillator
- ELAB 67.74
- EVGN 2.60
About ELAB Elevai Labs Inc.
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.